Drugs / Fluzone High-Dose
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04613206 | Jan 2021 → Jul 2026 overdue | disease related to solid organ transplantation, influenza | Vanderbilt University Medical Center | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone High-Dose | “Fluzone High-Dose (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs.” NCT04613206 ↗ |
| Known as | High Dose Quadrivalent Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04613206 ↗ |
| Modality | Vaccine | “is an inactivated influenza vaccine” NCT04613206 ↗ |
| Route | Intramuscular | “for intramuscular injection” NCT04613206 ↗ |